Gynecology and Vaccines

Vaccine is mostly 100% effective in inhibiting precancerous lesions of the cervix, vulva and vagina, and genital growths caused by HPV. Vaccination is the most effective tool to inhibit HPV infection and HPV-related disease. Vaccines are prophylactic, vaccination previously expose to HPV will result in the supreme public health benefit. Gynecologists and Obstetrician can play a vital role in decreasing morbidity and mortality from a variety of vaccine-preventable diseases, which includs pertussis, influenza, human papillomavirus, and hepatitis. One dose of Cervarix affords protection against HPV 16/18 infection with robust antibody titers well above natural infection titers.

    Related Conference of Gynecology and Vaccines

    May 21-22, 2026

    17th International Conference on Liver Diseases & Hepatology

    Aix-en-Provence, France
    June 18-19, 2026

    9th International Congress on Viral Hepatitis

    Paris, France
    August 03-04, 2026

    21st Euro-Global Gastroenterology Conference

    London, UK
    September 29-30, 2026

    7th Global Summit on Earth Science and Climate Change

    Aix-en-Provence, France

    Gynecology and Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in